Abbott Reports Strong Growth in First Quarter

The first quarter is in the books and Abbott showed strong results, positioning the company for long-term sustainable and organic growth.


For the quarter, we beat Street estimates on the top and bottom lines, and we expect to continue to deliver top-tier sales and double-digit EPS growth throughout 2018. With today’s results, Abbott has met or beaten Street adjusted EPS estimates every quarter for more than 10 years.

The strong growth we delivered this quarter is a direct result of the strategic steps we’ve taken to position the company in the most attractive areas of healthcare and the productivity of our technologies. In the first quarter:

We continued our leadership in Cardiovascular Devices through our rapidly growing portfolio.

We continued to revolutionize how people manage their diabetes.

We continue to personalize and harmonize the lab with our diagnostics technology.

Read more about the first quarter growth at Abbot.com.

Latest News

Facebook logo

Facebook Forced To Pay a Record $14-Million Settlement for Discriminating Against US Workers

October continues to be a month Facebook likely wishes it could forget. First came Frances Haugen, the whistleblower who explained in chilling detail how the site and its algorithms are designed to profit off what she called “the spread and amplification of hate, misinformation and political unrest.” Then there was…

United States Capitol Building

More Than 300 Black Congressional Staffers Decry Lack of Diversity on Capitol Hill; Challenge Lawmakers To ‘Do Better’

Regardless of which party is in power at any given time, people of color continue to be woefully underrepresented in not just elected office but also within support roles working for those lawmakers. And now, hundreds of these staffers are speaking out about what they call an “appalling” lack of…